logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

ImmunityBio Soars Over 30% as Bladder Cancer Drug Anktiva Delivers Breakout Growth

ImmunityBio Soars Over 30% as Bladder Cancer Drug Anktiva Delivers Breakout Growth

Jan 15, 2026

Life Science

2025年值得关注的三只金融科技股票

Three Promising Healthcare Stocks Poised to Maintain Their Leadership Position

Jan 14, 2026

Life Science

5 Pharma Stocks Offering 3%+ Dividend Yields for Uncertain Times

5 Pharma Stocks Offering 3%+ Dividend Yields for Uncertain Times

Jan 14, 2026

Life Science

回调中的白银在2026年是否迎来配置机遇?

UnitedHealth Faces Short-Term Pressure but Maintains Long-Term Potential 

Jan 14, 2026

Life Science

ExxonMobil: Oil Price Shock and a $151 Target – Time to Buy?

Eli Lilly and Novo Nordisk: The Battle for Dominance in the 2026 Weight-Loss Drug Market

Jan 13, 2026

Life Science

英伟达之后,博通将成为下一个2万亿美元芯片巨头

AI Giants Vie for New Track in Health Management, OpenAI Acquires Torch

Jan 12, 2026

Life Science, Technology

英特尔押注AI未来,传计划收购SambaNova

NVIDIA Partners with Eli Lilly to Establish Joint Laboratory

Jan 12, 2026

Life Science

美股牛市支柱动摇,企业盈利成中流砥柱

Medline’s Stock Price Soars After Market Debut, Wall Street Bullish on the “Aging Dividend”

Jan 12, 2026

Life Science

Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley

Can Obesity Drug Dark Horse GPCR Double Its Stock Price Again in 2026?

Jan 11, 2026

Life Science

避险需求助推金价上涨,黄金类资产投资价值凸显

Amazon Pharmacy Launches Oral Wegovy Sales, Presenting New Opportunity for Novo Nordisk 

Jan 9, 2026

Life Science

获亿万富翁重仓押注,梯瓦制药业绩与管线双驱动

Outlook for the U.S. Stock Market Healthcare Sector in 2026: Three Major Trends Reshaping Investment Logic

Jan 8, 2026

Life Science

剖析强生本月股价上涨动因

OpenAI Advances with Dual Focus: Targeting Healthcare and Hardware Interaction 

Jan 7, 2026

Life Science

French Biotech Abivax Soared 1,740% Last Year. Can the Rally Continue?

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio

Jan 7, 2026

Life Science

Can Viking Therapeutics Replicate Eli Lilly’s Success in the Weight-Loss Drug Market?

What Eli Lilly Offers Investors as It Nears a $1 Trillion Valuation

Jan 6, 2026

Life Science

美政府促成减肥药历史性降价,协议定价245美元

Analysts Optimistic About Prospects, UnitedHealth Group Stock Gets a Boost

Jan 6, 2026

Life Science

木头姐2026布局转向,重仓基因编辑技术

Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology

Jan 5, 2026

Life Science

诺和诺德首发口服减肥药,百亿美元市场格局生变

Novo Nordisk Launches Oral Weight-Loss Drug, Shifting the $100 Billion Market Landscape

Jan 5, 2026

Life Science

Amtagvi's Complex Path: Why Iovance Is Either a Home Run or a Strikeout

Nektar Therapeutics Too Risky? This Biotech Stock Offers a Safer Bet

Jan 5, 2026

Life Science

  • ‹‹ Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada